December 17, 2020 | Daily JAM, Dividend Income, PFE |
Next step approval for emergency use authorization from the Food & Drug Administration. Today, Thursday, December 17, a FDA advisory committee voted 20 to 0, with one abstention, that the benefits of the Moderna (MRNA) coronavirus vaccine outweigh any risk.
December 3, 2020 | Daily JAM, PFE |
Pfizer (PFE) stock tumbled Thursday after the company reportedly slashed its expectations for coronavirus vaccine deliveries in 2020 due to supply-chain issues. “Scaling up the raw material supply chain took longer than expected,” a company spokeswoman told the Wall Street Journal.
October 16, 2020 | Daily JAM, Dividend Income, PFE, Stock Alerts |
In a public letter Pfizer (PFE) CEO Albert Bourla wrote that the company hopes to have initial data from its Phase 3 clinical trail of a coronavirus vaccine by the end of October and that it will wait until the third week in November to file an emergency use...
August 28, 2020 | Daily JAM, Dividend Income, PFE, Stock Alerts |
You remember how in Part 3A of my Special Report: Meeting Your Retirement Challenge, I suggested that when temporary factors created an opportunity to buy the shares of a solid, predictable, cash flow generating company, with a yield of 4% you should jump at the...
September 11, 2019 | Daily JAM, PFE, Stock Alerts |
Why introduce legislation that will dead on arrival in the Republican controlled Senate? Because House Speaker Nancy Pelosi and other Democrats know that controlling drug prices is extremely popular with voters. And a proposal that is a serious effort to lower drug...
July 5, 2019 | Daily JAM, MRK, PFE |
It's good to know that in this sometimes confusing and volatile market some things remain constant. A high-profile figure says something about the need to lower drug prices and drug stocks tumble. Whether the "something" is likely to result in action or not. Today it...
February 26, 2019 | Daily JAM, Morning Briefing, MRK, PFE |
The format was familiar: Seven CEOs sit in front of a Senate Committee probing their industry's business practices. But whereas a Congressional hearing a decade ago marked a key moment in what was a costly public reckoning for the tobacco industry, today's hearing...
December 17, 2018 | Daily JAM, PFE, Stock Alerts |
I'm going to take advantage of the selling in the market in general and in the drug sector in particular--on news of the asbestos liability at Johnson & Johnson and fears of the death of Obamacare (AKA the Affordable Care Act)--to buy Pfizer (PFE) in my Dividend...
